Date: 11th July 2019
Location: Basement Lecture Theatre, 33 Queen Square, London, WC1N
Dr Jeremy Rees, PhD FRCP
Dr Jeremy Rees qualified in 1988 from University College and Middlesex Medical School with distinctions in Medicine, Surgery and Therapeutics. After postgraduate training, including a spell at Memorial Sloan Kettering Hospital, New York, in 1999 he was appointed as Honorary Senior Lecturer in Neuro-oncology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery. He specializes in the management of low-grade brain tumours and neurological complications of cancer.
Having been the Clinical Lead for the Brain Tumour Unit at UCLH and the Pathway Director for Brain Cancer at London Cancer, he is now a member of the NICE Guidelines Committee for writing national guidelines on the treatment of brain tumours. He leads a research team investigating the role of multimodality imaging in the management of Low Grade Gliomas, has edited a textbook on Neuro-oncology, written numerous peer-reviewed research papers and chapters on Neuro-oncology and lectures extensively to different professional groups.
Dr Gary Hotton
Dr Gary Hotton qualified from University College and Middlesex School of Medicine in 1995. Dr Hotton is a Consultant Neurologist and divides his time between the National Hospital for Neurology and Neurosurgery (NHNN) and The North Middlesex Hospital. At the NHNN he has a specialist neuro-oncology clinic and is a core member of the neuro-oncology multidisciplinary team. His main research interest is in brain tumor related epilepsy.
Dr Kate Cwynarski
Dr Kate Cwynarski is a Haem-Oncologist specialising in Lymphoma and CLL at University College London Hospital, London, UK. She trained at King's College, Hammersmith Hospital and Royal Free Hospital, London UK and received her MRC-funded PhD in immunology at Imperial College, London, UK.
Her sub-specialist interests include Primary Central Nervous System (CNS) Lymphoma, HIV-related lymphoma and T-cell Lymphomas. She is Co-lead of the UK Primary CNS Lymphoma (PCNSL) Group and a member of the European CNS Lymphoma Group. She is a core member of the National Cancer Research Institute (NCRI) Lymphoma Clinical Studies Group and Lymphoma Specialist Group of the British Society of Haematology.
Dr. Cwynarski is involved in many clinical trials, has co-authored BCSH guidelines and she has authored or co-authored over 60 journal articles in Lancet Haematology, Journal of Clinical Oncology, Blood, AIDS, British Journal of Haematology and Bone Marrow Transplant
Dr Ronan Burke
Dr. Ronan Burke is the neuropsychology lead for the neuro-oncology service. He qualified as a clinical psychologist from University College London and initially worked in an older adults dementia care team and diagnostic memory clinic, before moving to the National Hospital for Neurology and Neurosurgery (NHNN) in 2013. With his interest in providing maximal neuropsychological support for patients with brain tumour, through cognitive assessment, rehabilitation and psychological interventions to facilitate adjustment, he has expanded the neuropsychological service, especially to optimise psychological support for patients with low grade tumours. His opinion is often sought from clinicians within London Cancer seeking advice on neuropsychological issues. He has given talks on his work with brain tumour patients to Brain Tumour Charity patient information days, at London Cancer events and he has lectured on the UCL doctoral clinical psychology training course. He is also involved in ongoing research projects within the neuro-oncology service.
Dr Rachel Farrell
Dr Jon Martin
Jon is a consultant in palliative medicine and the clinical lead for the palliative care service, Central and North West London NHS Foundation Trust; he leads on the provision of palliative care at the National Hospital for Neurology & Neurosurgery, part of the University College Hospitals London NHS Foundation Trust.
His clinical interests include people with neurological and neuro-oncological disease, non-cancer respiratory disease, advance care planning and psycho-spiritual care. He has a long-standing interest in the interface between medical ethics and medical law and is a mindfulness-based meditation practitioner.